Skip to search.
 NZX 50 Up 0.49%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
7.98 Up 0.23(2.97%) 1 Aug 08:00
|After Hours : 7.98 0.00 (0.00%) 1 Aug 08:43
Add to Portfolio
Prev Close:7.75
Open:7.78
Bid:7.60 x 500
Ask:8.40 x 2300
1y Target Est:20.33
Beta:6.83
Next Earnings Date: 5-Aug-15KERX Earnings announcement
Day's Range:7.78 - 8.13
52wk Range:7.29 - 18.48
Volume:1,591,666
Avg Vol (3m):1,751,060
Market Cap:826.70m
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 2.97%826.70m
BAXUp 0.17%21.78b
SHPGUp 1.63%52.52b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):401.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.92
Quarterly EPS Est (Jun-15) :-0.26
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback